SenzaGen AB (STO:SENZA)
5.32
-0.02 (-0.37%)
Jul 20, 2026, 11:01 AM CET
SenzaGen AB Revenue
SenzaGen AB had revenue of 14.96M SEK in the quarter ending March 31, 2026, with 9.52% growth. This brings the company's revenue in the last twelve months to 59.28M, up 3.96% year-over-year. In the year 2025, SenzaGen AB had annual revenue of 57.97M with 0.48% growth.
Revenue (ttm)
59.28M
Revenue Growth
+3.96%
P/S Ratio
2.93
Revenue / Employee
1.80M
Employees
33
Market Cap
173.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.97M | 279.00K | 0.48% |
| Dec 31, 2024 | 57.70M | 7.83M | 15.69% |
| Dec 31, 2023 | 49.87M | 8.10M | 19.39% |
| Dec 31, 2022 | 41.77M | 26.35M | 170.85% |
| Dec 31, 2021 | 15.42M | 7.46M | 93.79% |
| Dec 31, 2020 | 7.96M | 5.23M | 192.14% |
| Dec 31, 2019 | 2.72M | -6.81M | -71.42% |
| Dec 31, 2018 | 9.53M | -1.06M | -10.02% |
| Dec 31, 2017 | 10.59M | 7.76M | 274.05% |
| Dec 31, 2016 | 2.83M | -951.00K | -25.14% |
| Dec 31, 2015 | 3.78M | 2.16M | 132.94% |
| Dec 31, 2014 | 1.62M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.24B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Sectra AB | 3.65B |
| Camurus AB | 2.27B |
| Elicera Therapeutics AB | 10.64M |
| iZafe Group AB | 7.09M |
| Xintela AB | 2.59M |
| Simris Group AB (PUBL) | 1.88M |
SenzaGen AB News
- 2 months ago - SenzaGen AB Quarterly report: Q1 2026 - Filings
- 2 months ago - SenzaGen AB Slides: Q1 2026 - Filings
- 5 months ago - SenzaGen AB Quarterly report: Q4 2025 - Filings
- 5 months ago - SenzaGen AB Slides: Q4 2025 - Filings
- 5 months ago - SenzaGen AB Annual report: Q4 2025 - Filings
- 8 months ago - SenzaGen AB Transcript: Life Science Summit 2025 - Transcripts
- 9 months ago - SenzaGen AB Transcript: CMD 2025 - Transcripts
- 9 months ago - SenzaGen AB Press release: FY 2025 - Filings